mesenchymal stem cells

[Vitti Labs (PR Newswire, Inc.)] Vitti Labs announced that the US FDA has approved its Investigational New Drug (IND) application to conduct Phase II Clinical Trials using a combination of umbilical cord mesenchymal stem cell and umbilical cord mesenchymal stem cell exosomes for the treatment of Acute Respiratory Distress Syndrome associated with COVID-19.

[Advanced Healthcare Materials] Investigators presented a high-throughput, scalable, low-cost, on-chip microfluidic potency assay with improved functional predictive power and recapitulation of in vivo secretory responses compared to traditional approaches.

[Cell Death Discovery] The authors investigated the effects of wild-type p53-induce phosphatase 1 (Wip1) on regulating MSCs immunosuppressive capacities in type 1 diabetes mellitus mice.

[Experimental Cell Research] Investigators evaluated the application of injectable platelet rich fibrin (i-PRF) in human hair follicle regeneration by examining the biological effects of i-PRF on human dermal papilla cells.

[Life Sciences] After induction of the Alzheimer's disease model, the rats were transplanted with deferoxamine-preconditioned adipose-derived mesenchymal stem cells or untreated cells.

[International Journal of Stem Cells] Investigators introduced a rat model of liver fibrosis and trans-portal transplantation of human liver stem cells to demonstrate alleviation of liver fibrosis.